Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience.
COVID-19
SARS-CoV2
acute myeloid leukemia
coronavirus
pandemic
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
06
05
2020
accepted:
29
07
2020
entrez:
28
9
2020
pubmed:
29
9
2020
medline:
29
9
2020
Statut:
epublish
Résumé
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent pandemic have impacted every aspect of oncology care worldwide. Healthcare systems have been forced to rapidly change practices in order to maximize the safety of patients and healthcare providers and preserve scare resources. Patients with acute myeloid leukemia are at increased risk of complications from SARS-CoV-2 not only due to immune compromise related to the malignancy but also due to the acuity of the disease and intensity of treatment. These issues have created unique challenges during this difficult time. In this article, we present the approaches taken by two groups of hematologist/oncologists, one in the United States and one in Italy, who have been caring for acute myeloid leukemia (AML) patients in the face of the pandemic.
Identifiants
pubmed: 32984046
doi: 10.3389/fonc.2020.01689
pmc: PMC7492670
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1689Informations de copyright
Copyright © 2020 Wilde, Isidori, Keiffer, Palmisiano and Kasner.
Références
Hematol Oncol. 2016 Sep;34(3):147-53
pubmed: 25641349
N Engl J Med. 2014 Oct 9;371(15):1381-91
pubmed: 25270275
N Engl J Med. 1997 Dec 25;337(26):1870-5
pubmed: 9407153
J Clin Oncol. 1997 Mar;15(3):1143-9
pubmed: 9060557
Leukemia. 2019 Nov;33(11):2575-2584
pubmed: 30967620
Ann Hematol. 2020 Jul;99(7):1677-1678
pubmed: 32535706
Lancet. 2015 Jul 11;386(9989):137-44
pubmed: 25956718
JAMA. 2010 Oct 13;304(14):1559-67
pubmed: 20940381
Ann Oncol. 2006 May;17(5):763-8
pubmed: 16497826
Blood. 2009 Jan 1;113(1):28-36
pubmed: 18827183
Expert Rev Hematol. 2013 Dec;6(6):767-84
pubmed: 24219553
Blood. 2019 Jan 3;133(1):7-17
pubmed: 30361262
Blood Cancer J. 2017 May 26;7(5):e564
pubmed: 28548643
Leukemia. 2019 Feb;33(2):379-389
pubmed: 30555165
Eur J Haematol. 1995 Jan;54(1):18-20
pubmed: 7859871
Blood. 2020 Aug 13;136(7):823-830
pubmed: 32496541
Leuk Lymphoma. 2001 Jul;42(3):339-46
pubmed: 11699398
Haematologica. 2011 Jun;96(6):914-7
pubmed: 21393334
Cancer. 2013 Nov 1;119(21):3784-7
pubmed: 23921838
N Engl J Med. 2017 Nov 30;377(22):2133-2144
pubmed: 29130845
Cancer Discov. 2020 Apr;10(4):506-525
pubmed: 32014868
Biol Blood Marrow Transplant. 2002;8(10):569-76
pubmed: 12434952
Eur J Haematol. 1990 Aug;45(2):86-9
pubmed: 2209824
N Engl J Med. 1999 Feb 11;340(6):409-17
pubmed: 9971864
Haematologica. 1998 Nov;83(11):998-1000
pubmed: 9864920
JAMA Oncol. 2015 Nov;1(8):1120-7
pubmed: 26355382
N Engl J Med. 2013 Jan 3;368(1):11-21
pubmed: 23281973
N Engl J Med. 2015 Mar 12;372(11):997-1008
pubmed: 25760354